- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03790748
Regional Blocks of Gynecological Surgeries
August 27, 2021 updated by: Reham Ali Abdelhaleem Abdelrahman, Cairo University
Comparison of Dural Puncture Epidural Technique Versus Conventional Epidural Technique for Adequate Anesthesia During Vaginal Surgeries
This study will be conducted on 273 patients of ASA grade I and II aged from 25 to 55 years and presented for elective vaginal surgeries such as vaginal hysterectomy, repair of prolapse Patients will be divided into three equal groups; group A control group for conventional epidural technique(n=91), group B for dural puncture epidural with 27G pencil point Whitacre spinal needle (n=91) and group C for dural puncture epidural with 25G pencil point Whitacre spinal needle(n=91).
Randomization will be done using computer generated number and concealed using sequentially numbered sealed opaque envelope.
Study Overview
Status
Completed
Study Type
Interventional
Enrollment (Actual)
273
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cairo, Egypt, 11562
- Department of Anesthesia, Surgical ICU, and Pain Management
-
Cairo, Egypt, 11562
- Reham Ali Abdelrahman
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 55 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- ASA I and II
- Height(150-170 cm)
Exclusion Criteria:
- patient refusal
- hypersensitivity to local anesthetic drugs
- bleeding disorders and coagulopathy(platelets count less than 80000,INR less than 1.5 or therapeutic dose of anticoagulant).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Conventional Epidural Technique
Procedure: Standard Lumbar Epidural Block using Touhy Epidural Needle (18G) at L4-5 inter-space and Epidural Catheter (20G) was inserted then bupivacaine 0.5% 15-20 ml with 50ug fentanyl was given.
|
25G Dural Puncture Epidural Technique at L4-5 inter-space using 0.5%Bupivacaine and Fentanyl.
27G Dural Puncture Epidural Technique at L4-5 inter-space using 0.5%Bupivacaine and Fentanyl.
|
Active Comparator: Dural Puncture Epidural Technique using pencil-point 25G Whitacre needle
Procedure: 25G Dural Puncture Epidural Block at L4-5 inter-space then bupivacaine 0.5% 15-20 ml with 50ug fentanyl was given.
|
27G Dural Puncture Epidural Technique at L4-5 inter-space using 0.5%Bupivacaine and Fentanyl.
Standard Lumbar Epidural Technique at L4-5 inter-space using 0.5%Bupivacaine and Fentanyl.
|
Active Comparator: Dural Puncture Epidural Technique using pencil-point 27G Whitacre needle
Procedure: 27G Dural Puncture Epidural Block at L4-5 inter-space then bupivacaine 0.5% 15-20 ml with 50ug fentanyl was given.
|
25G Dural Puncture Epidural Technique at L4-5 inter-space using 0.5%Bupivacaine and Fentanyl.
Standard Lumbar Epidural Technique at L4-5 inter-space using 0.5%Bupivacaine and Fentanyl.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
incidence of bilateral sacral blockade
Time Frame: Up to 30 minutes after local anesthetic injection
|
Sensory blockade was evaluated using a non-traumatic pinprick stimulus starting at the S2 dermatome and moving in a caudad direction (measured every 2 minutes)
|
Up to 30 minutes after local anesthetic injection
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Onset of sensory blockade
Time Frame: Up to 30 minutes after local anesthetic injection
|
Up to 30 minutes after local anesthetic injection
|
|
Maximum achieved sensory level
Time Frame: Up to 30 minutes after local anesthetic injection
|
Up to 30 minutes after local anesthetic injection
|
|
Time to achieve the maximum sensory level
Time Frame: Up to 30 minutes after local anesthetic injection
|
Up to 30 minutes after local anesthetic injection
|
|
Onset of motor blockade
Time Frame: Up to 30 minutes after local anesthetic injection
|
Up to 30 minutes after local anesthetic injection
|
|
Time to complete motor block
Time Frame: Up to 30 minutes after local anesthetic injection
|
Up to 30 minutes after local anesthetic injection
|
|
Duration of sensory block
Time Frame: Assessed every 20 minutes after achieving highest dermatome level of sensory analgesia
|
Time to two segmental dermatomes regression
|
Assessed every 20 minutes after achieving highest dermatome level of sensory analgesia
|
Duration of motor block
Time Frame: Assessed every 20 minutes after achieving Bromage 3 motor block
|
Time interval from achievement of Bromage 1 to regression of motor blockade to Bromage 1
|
Assessed every 20 minutes after achieving Bromage 3 motor block
|
Duration of analgesia
Time Frame: Time for requirement for rescue analgesia or VAS pain score >3 as postoperatively
|
Time from onset of sensory block to first complain of pain postoperatively as the epidural catheter will be removed after the surgery finished
|
Time for requirement for rescue analgesia or VAS pain score >3 as postoperatively
|
Number of epidural top-ups
Time Frame: Number of extra doses of local anesthetic given after injection of local anesthetic loading dose till end of the surgery
|
Number of extra doses of local anesthetic given after injection of local anesthetic loading dose till end of the surgery
|
|
Sedation score
Time Frame: Assessed every 20 minutes during the surgical procedure and postoperatively
|
Assessed every 20 minutes during the surgical procedure and postoperatively
|
|
Hemodynamic parameters
Time Frame: Assessed every 5 minutes from the start of anesthetic procedures till transfer the patients to the rooms
|
Assessed every 5 minutes from the start of anesthetic procedures till transfer the patients to the rooms
|
|
Perioperative side effects
Time Frame: During surgical period up to 7 days post-operatively
|
During surgical period up to 7 days post-operatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Reham Ali Abdelrahman, M.D., Cairo University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2019
Primary Completion (Actual)
June 28, 2021
Study Completion (Actual)
July 31, 2021
Study Registration Dates
First Submitted
December 23, 2018
First Submitted That Met QC Criteria
December 31, 2018
First Posted (Actual)
January 2, 2019
Study Record Updates
Last Update Posted (Actual)
September 1, 2021
Last Update Submitted That Met QC Criteria
August 27, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IUD2900
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gynecologic Disease Requiring Vaginal Operation Under Neuraxial Anesthesia
-
Cairo UniversityCompletedGynecologic Disease Requiring Laparoscopic Hysterectomy Under Neuraxial AnesthesiaEgypt
-
Cairo UniversityCompletedGynecologic Diseases Requiring Vaginal HysterectomyEgypt
Clinical Trials on 25G Dural Puncture Epidural Technique
-
Cairo UniversityCompletedGynecologic Diseases Requiring Vaginal HysterectomyEgypt
-
Reham Ali Abdelhaleem AbdelrahmanCompleted
-
Mayo ClinicUniversity of British ColumbiaEnrolling by invitationAnalgesia | AnesthesiaUnited States, Canada
-
Cairo UniversityCompletedGynecologic Disease Requiring Laparoscopic Hysterectomy Under Neuraxial AnesthesiaEgypt
-
University of ChileCompletedEpidural Analgesia | Labor PainChile
-
Medical University of South CarolinaCompletedLabor Pain | Labor AnalgesiaUnited States
-
University of ArkansasCompleted
-
National Research Centre, EgyptCairo UniversityWithdrawnDural Puncture Epidural Technique
-
Cairo UniversityActive, not recruitingDural Puncture Epidural TechniqueEgypt
-
Brigham and Women's HospitalCompletedLaboring Women Requesting Neuraxial Labor AnalgesiaUnited States